Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C08CA01	AMLO TAD	G	Amlodipine besylate - 5mg	5mg	Tablet	744,489 L.L
N02BE01	ALGIVIC INFANT	G	Paracetamol - 125mg	125mg	Suppository	199,657 L.L
C08CA01	AMLOCARD	G	Amlodipine (besylate) - 5mg	5mg	Tablet	473,545 L.L
B05XA31	ADDAVEN	G	Chromic chloride 6H2O - 53mcg/10ml, Copper chloride dihydrate - 1.02mg/10ml, Ferric Chloride hexahydrate - 5.40mg/10ml, Manganese chloride 4H2O - 198mcg/10ml, Potassium iodide - 166mcg/10ml, Sodium fluoride - 2.10mg/10ml		Injectable concentrate for solution	4,065,124 L.L
C08CA01	AMLOCOEUR	G	Amlodipine - 5mg	5mg	Tablet	362,198 L.L
C08CA01	AMLODAR 5	G	Amlodipine (besylate) - 5mg	5mg	Capsule	362,837 L.L
C08CA01	AMLODIPINE ARROW	G	Amlodipine (besylate) - 5mg	5mg	Capsule	462,282 L.L
M01AX21	ART	G	Diacerein - 50mg	50mg	Capsule	1,146,298 L.L
C08CA01	AMLODIPINE BIOGARAN	G	Amlodipine (besylate) - 5mg	5mg	Capsule	462,282 L.L
C08CA01	AMLOPHAR	G	Amlodipine (besylate) - 5mg	5mg	Capsule	388,370 L.L
C08CA01	AMLORINE 5	G	Amlodipine (besylate) - 5mg	5mg	Tablet	388,370 L.L
A10BB12	AMEPRIDE	G	Glimepiride - 4mg	4mg	Tablet	215,015 L.L
C08CA01	AMOPRO	G	Amlodipine (besylate) - 5mg	5mg	Capsule	362,837 L.L
R03BA02	AERONIDE	G	Budesonide - 200mcg	200mcg	Capsule, inhalation	1,150,329 L.L
M02AA10	ACHONID GEL	G	Ketoprofen - 2.5%	2.5%	Gel	179,179 L.L
S01AE07	AROX	G	Moxifloxacin (HCl) - 0.5%	0.5%	Drops	423,310 L.L
B01AB11	ANGIOFLUX	G	Sulodexide - 250LRU	250LRU	Capsule, soft	2,026,514 L.L
A04AA01	APO-ONDANSETRON	G	Ondansetron - 8mg	8mg	Tablet	1,491,665 L.L
C08CA01	AMLINE	G	Amlodipine - 10mg	10mg	Tablet	662,962 L.L
C08CA01	AMLOCARD 10	G	Amlodipine (besylate) - 10mg	10mg	Tablet	870,298 L.L
D04AB01	AVOCAINE	G	Lidocaine - 10%	10%	Spray	400,465 L.L
L01BC07	AZACITIDINE ARROW	G	Azacitidine - 25mg/ml	25mg/ml	Injectable suspension	10,967,854 L.L
N02BE01	ADOL	G	Paracetamol - 250mg/5ml	250mg/5ml	Suspension, alcohol free	192,169 L.L
C08CA01	AMLODAR 10	G	Amlodipine (besylate) - 10mg	10mg	Capsule	671,921 L.L
L01BC07	AZACITIDINE EVER PHARMA	G	Azacitidine - 100mg/100ml	25mg/ml	Injectable powder for suspension	10,967,854 L.L
C08CA01	AMLODIPINE ARROW	G	Amlodipine (besylate) - 10mg	10mg	Capsule	462,282 L.L
L01BC07	AZACITIDINE NEAPOLIS	G	Azacitidine - 100mg	100mg	Injectable lyophilised powder	9,401,575 L.L
C08CA01	AMLODIPINE BIOGARAN	G	Amlodipine (besylate) - 10mg	10mg	Capsule	462,282 L.L
L01BC07	AZACITIDINE SHILPA	G	Azacitidine - 100mg	100mg	Injectable powder	7,350,062 L.L
R03BA02	AERONIDE	G	Budesonide - 400mcg	400mcg	Capsule, inhalation	2,116,552 L.L